BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the following healthcare conferences during November 2014:
•Credit Suisse 2014 Healthcare Conference in Phoenix on Wednesday, November 12, 2014 at 3:30 p.m. MST.
Help employers find you! Check out all the jobs and post your resume.
